Tirzepatide introduces both potential benefits and concerns in this area that deserve careful consideration
The obesity segment is the fastest-growing segment in the market, driven by the increasing awareness of dietary changes, increased physical activity, and weight management
Mood-related benefits : Bupropion may offer mild antidepressant effects, which could be an added benefit for some
The three FDA-approved injection sites Every GLP-1 receptor agonist currently approved for weight loss uses the same three injection sites
Omzo's primary offering is compounded medication
He provides physician-led care focused on medication tolerability, long-term metabolic outcomes, and safe, sustainable weight loss through both in-person and telehealth visits across Southern and Northern Utah